featured
Conditional Recurrence-Free Survival of Clinical Complete Responders Managed by Watch and Wait After Neoadjuvant Chemoradiotherapy for Rectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Conditional Recurrence-Free Survival of Clinical Complete Responders Managed by Watch and Wait After Neoadjuvant Chemoradiotherapy for Rectal Cancer in the International Watch & Wait Database: A Retrospective, International, Multicentre Registry Study
Lancet Oncol 2020 Dec 11;[EPub Ahead of Print], LM Fernandez, GP São Julião, NL Figueiredo, GL Beets, MJM van der Valk, RR Bahadoer, DE Hilling, E Meershoek-Klein Kranenbarg, AGH Roodvoets, AG Renehan, CJH van de Velde, A Habr-Gama, RO PerezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.